BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9830445)

  • 1. [How toxic and effective is simultaneous radiochemotherapy with hydroxyurea, 5-FU and cisplatin in cervix carcinoma?].
    Lindner H
    Strahlenther Onkol; 1998 Nov; 174(11):601-2. PubMed ID: 9830445
    [No Abstract]   [Full Text] [Related]  

  • 2. [Postoperative simultaneous radiochemotherapy improves survival in patients with cervical carcinoma].
    Dunst J
    Strahlenther Onkol; 2000 Oct; 176(10):486-7. PubMed ID: 11068599
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
    Whitney CW; Sause W; Bundy BN; Malfetano JH; Hannigan EV; Fowler WC; Clarke-Pearson DL; Liao SY
    J Clin Oncol; 1999 May; 17(5):1339-48. PubMed ID: 10334517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy].
    Kaneyasu Y; Okawa MK; Kokubo N; Karasawa K; Fukuhara N; Toda J; Okawa T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1813-6. PubMed ID: 9382539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I-II study of combined 5-fluorouracil and cisplatin chemotherapy and altered fractionation radiotherapy for advanced squamous cell carcinoma of the cervix.
    Fishman A; Chiu JK; Girtanner RE; Dennis W; Carpenter LS; Lu HH; Woo SY; Kerley JM; Kaplan AL
    Am J Clin Oncol; 1997 Aug; 20(4):342-7. PubMed ID: 9256886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.
    Rakovitch E; Fyles AW; Pintilie M; Leung PM
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):979-87. PubMed ID: 9276362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging.
    Marnitz S; Köhler C; Roth C; Füller J; Bischoff A; Wendt T; Schneider A; Budach V
    Strahlenther Onkol; 2007 Sep; 183(9):473-8. PubMed ID: 17762920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128.
    Gaffney DK; Winter K; Dicker AP; Miller B; Eifel PJ; Ryu J; Avizonis V; Fromm M; Small W; Greven K
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):111-7. PubMed ID: 17482376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation myelitis: a complication of concurrent cisplatin and 5-fluorouracil chemotherapy with extended field radiotherapy for carcinoma of the uterine cervix.
    Bloss JD; DiSaia PJ; Mannel RS; Hyden EC; Manetta A; Walker JL; Berman ML
    Gynecol Oncol; 1991 Dec; 43(3):305-8. PubMed ID: 1752503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoropyrimidine anticancer agent for locally advanced carcinoma of the uterine cervix: a prospective follow-up study.
    Nagai N; Oshita T; Murakami J; Shigemasa K; Hirokawa Y; Ohama K
    Oncol Rep; 2001; 8(1):119-25. PubMed ID: 11115582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer.
    Christie DR; Bull CA; Gebski V; Langlands AO
    Radiother Oncol; 1995 Dec; 37(3):181-9. PubMed ID: 8746586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Hsueh S; Chen CK; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):429-36. PubMed ID: 20542643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concomitant radiochemotherapy in cancer of the cervix uteri: modifications of the standards].
    Haie-Meder C; Lhommé C; de Crevoisier R; Morice P; Resbeut M
    Cancer Radiother; 2000 Nov; 4 Suppl 1():134s-140s. PubMed ID: 11194951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
    Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
    Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.